{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:40:38Z","timestamp":1780566038865,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["Project No. 08191526"],"award-info":[{"award-number":["Project No. 08191526"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["No. 2021YFC2701600"],"award-info":[{"award-number":["No. 2021YFC2701600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-023-07257-5","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T05:01:52Z","timestamp":1698296512000},"page":"981-990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A point-of-care urine test to predict adverse maternal and neonatal outcomes in Asian women with suspected preeclampsia"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-8476","authenticated-orcid":false,"given":"Natalie K. L.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Y. M.","family":"Wah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sani T. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Nguyen-Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn S. L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia N. P.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary H. Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljit S.","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"issue":"7","key":"7257_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA (2019) Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 124(7):1094\u20131112","journal-title":"Circ Res"},{"issue":"3","key":"7257_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130\u2013137","journal-title":"Semin Perinatol"},{"issue":"5","key":"7257_CR3","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","volume":"77","author":"JM Roberts","year":"2021","unstructured":"Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L, Global PC (2021) Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension 77(5):1430\u20131441","journal-title":"Hypertension"},{"issue":"7","key":"7257_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350(7):672\u2013683","journal-title":"N Engl J Med"},{"issue":"5728","key":"7257_CR5","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308(5728):1592\u20131594","journal-title":"Science"},{"issue":"8","key":"7257_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1055\/a-1403-2576","volume":"81","author":"O Graupner","year":"2021","unstructured":"Graupner O, Enzensberger C (2021) Prediction of adverse pregnancy outcome related to placental dysfunction using the sFlt-1\/PlGF ratio: a narrative review. Geburtshilfe Frauenheilkd 81(8):948\u2013954","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"7","key":"7257_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ et al (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125(7):911\u2013919","journal-title":"Circulation"},{"issue":"1","key":"7257_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H et al (2012) The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 206(1):58","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"7257_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/uog.13224","volume":"43","author":"PI Gomez-Arriaga","year":"2014","unstructured":"Gomez-Arriaga PI, Herraiz I, Lopez-Jimenez EA, Escribano D, Denk B, Galindo A (2014) Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol 43(5):525\u2013532","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"7257_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00404-018-4840-3","volume":"298","author":"O Graupner","year":"2018","unstructured":"Graupner O, Lobmaier SM, Ortiz JU, Karge A, Kuschel B (2018) sFlt-1\/PlGF ratio for the prediction of the time of delivery. Arch Gynecol Obstet 298(3):567\u2013577","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"7257_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","volume":"74","author":"X Bian","year":"2019","unstructured":"Bian X, Biswas A, Huang X, Lee KJ, Li TK, Masuyama H et al (2019) Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in asian women with suspected preeclampsia. Hypertension 74(1):164\u2013172","journal-title":"Hypertension"},{"key":"7257_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preghy.2021.12.008","volume":"27","author":"L Bremner","year":"2022","unstructured":"Bremner L, Gill C, Seed PT, Conti-Ramsden F, Webster L, Fleminger J et al (2022) Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio. Pregnancy Hypertens 27:96\u2013102","journal-title":"Pregnancy Hypertens"},{"issue":"245","key":"7257_CR13","doi-asserted-by":"publisher","first-page":"245ra92","DOI":"10.1126\/scitranslmed.3008808","volume":"6","author":"IA Buhimschi","year":"2014","unstructured":"Buhimschi IA, Nayeri UA, Zhao G, Shook LL, Pensalfini A, Funai EF et al (2014) Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med 6(245):245ra92","journal-title":"Sci Transl Med"},{"key":"7257_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.preghy.2021.06.004","volume":"25","author":"MPA Sailakshmi","year":"2021","unstructured":"Sailakshmi MPA, Prabhu MR, Prabhakara S, Anbazhagan K, Rupakala BM (2021) Congo red dot test in the early prediction and diagnosis of pre-eclampsia in a tertiary health care centre in India. Pregnancy Hypertens 25:225\u2013229","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"7257_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ajog.2016.04.041","volume":"215","author":"FP McCarthy","year":"2016","unstructured":"McCarthy FP, Adetoba A, Gill C, Bramham K, Bertolaccini M, Burton GJ et al (2016) Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension. Am J Obstet Gynecol 215(4):464","journal-title":"Am J Obstet Gynecol"},{"key":"7257_CR16","doi-asserted-by":"publisher","first-page":"100678","DOI":"10.1016\/j.eclinm.2020.100678","volume":"31","author":"H Bracken","year":"2021","unstructured":"Bracken H, Buhimschi IA, Rahman A, Smith PRS, Pervin J, Rouf S et al (2021) Congo red test for identification of preeclampsia: results of a prospective diagnostic case-control study in Bangladesh and Mexico. EClinicalMedicine 31:100678","journal-title":"EClinicalMedicine"},{"key":"7257_CR17","doi-asserted-by":"publisher","first-page":"700157","DOI":"10.3389\/fmed.2021.700157","volume":"8","author":"B Cai","year":"2021","unstructured":"Cai B, Yuan X, Li X, Xu J, Du J (2021) Urinary Congophilia Confirmed With the CapCord Test Is Associated With Pregnancy Outcomes in Women With Early-Onset Pre-eclampsia. Front Med (Lausanne) 8:700157","journal-title":"Front Med (Lausanne)"},{"key":"7257_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.preghy.2023.03.003","volume":"32","author":"STK Wong","year":"2023","unstructured":"Wong STK, Sahota DS, Wong NKL, Wah IYM, Wang X, Lau SL et al (2023) A point-of care urine test to predict preeclampsia development in Asian women with suspected preeclampsia. Pregnancy Hypertens 32:28\u201334","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"7257_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S et al (2018) Hypertensive disorders of pregnancy: isshp classification, diagnosis, and management recommendations for international practice. Hypertension 72(1):24\u201343","journal-title":"Hypertension"},{"key":"7257_CR20","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: Diagnosis and management NG133 [Internet]. London: NICE; 2019 [updated Apr 17 2023; cited 2023 Oct 15]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng133"},{"issue":"6","key":"7257_CR21","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia (2020) ACOG Practice bulletin, number 222. Obstet Gynecol 135(6):e237\u2013e260","journal-title":"Obstet Gynecol"},{"key":"7257_CR22","unstructured":"Hong Kong College of Obstetricians and Gynaecologists. OBSTETRICS AUDIT FORM [Internet]. Hong Kong: HKCOG; 2019 [cited 2023 Oct 15]. Available from: https:\/\/www.hkcog.org.hk\/hkcog\/Upload\/EditorImage\/20181113\/20181113110035_9344.pdf"},{"issue":"2","key":"7257_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","volume":"77","author":"LA Droge","year":"2021","unstructured":"Droge LA, Perschel FH, Stutz N, Gafron A, Frank L, Busjahn A et al (2021) Prediction of preeclampsia-related adverse outcomes with the sflt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension 77(2):461\u2013471","journal-title":"Hypertension"},{"key":"7257_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.preghy.2022.10.003","volume":"30","author":"M Kumar","year":"2022","unstructured":"Kumar M, Balyan K, Debnath E, Shankar S, Apte A, Jha S (2022) Role of sFLT-1\/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women. Pregnancy Hypertens 30:154\u2013160","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"7257_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/uog.24918","volume":"60","author":"YMI Wah","year":"2022","unstructured":"Wah YMI, Sahota DS, Chaemsaithong P, Wong L, Kwan AHW, Ting YH et al (2022) Impact of replacing or adding pregnancy-associated plasma protein-A at 11\u201313 weeks on screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol 60(2):200\u2013206","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"7257_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ajog.2008.07.006","volume":"199","author":"IA Buhimschi","year":"2008","unstructured":"Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Bernstein IM et al (2008) Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 199(5):551","journal-title":"Am J Obstet Gynecol"},{"key":"7257_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.eclinm.2019.02.004","volume":"8","author":"KM Rood","year":"2019","unstructured":"Rood KM, Buhimschi CS, Dible T, Webster S, Zhao G, Samuels P et al (2019) Congo red dot paper test for antenatal triage and rapid identification of preeclampsia. EClinicalMedicine 8:47\u201356","journal-title":"EClinicalMedicine"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07257-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:05:53Z","timestamp":1721311553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07257-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["7257"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07257-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration, and has been approved by the Joint Chinese University of Hong Kong\u2014New Territories East Cluster Clinical Research Ethics Committee (CREC Ref No: 2019.484).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individuals included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"LC Poon has received speaker fees and consultancy payments from Roche Diagnostics and Ferring Pharmaceuticals. In addition, she has received in-kind contributions from Roche Diagnostics, PerkinElmer, Thermo Fisher Scientific, and GE Healthcare. DS Sahota has received in-kind contributions from PerkinElmer, BRAHMS Thermo Fisher Scientific. Other authors report no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}